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NOTE
Proving Personal Use: The Admissibility of Evidence
Negating Intent to Distribute Marijuana
Stephen Mayer*
Against the backdrop of escalating state efforts to decriminalize marijuana,
U.S. Attorneys’ Offices continue to bring drug-trafficking prosecutions against
defendants carrying small amounts of marijuana that are permitted under
state law. Federal district courts have repeatedly barred defendants from intro-
ducing evidence that they possessed this marijuana for their own personal use.
This Note argues that district courts should not exclude three increasingly
common kinds of “personal use evidence” under Federal Rules of Evidence 402
and 403 when that evidence is offered to negate intent to distribute mari-
juana. Three types of personal use evidence are discussed in this Note: (1) a
defendant’s possession of a state-issued medical marijuana license, (2) evi-
dence that a state has legalized possession of marijuana for recreational pur-
poses, and (3) evidence that a defendant suffers from a disease that marijuana
arguably treats. Part I examines each of these three categories of personal use
evidence and contends that district courts are likely to confront disputes over
such evidence with increasing frequency. Part II analyzes objections to the
admissibility of personal use evidence on direct examination, focusing prima-
rily on Rules 402 and 403. Part III responds to those objections and argues
that the evidence is probative of intent to distribute in federal marijuana-
trafficking prosecutions.
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Introduction
In the spring of 2011, DEA Agents searched the home of a Michigan
resident named Ricky Brown.1 They suspected Mr. Brown of selling illegal
drugs.2 The agents found 2.1 ounces of marijuana and a firearm in his
house.3 The United States Attorney’s Office charged Mr. Brown with posses-
sion of marijuana with intent to distribute and possession of a firearm in
furtherance of a drug-trafficking crime.4 At first glance, this fact pattern
seems unremarkable—a standard enforcement action furthering the United
States’ “War on Drugs.” But one factual wrinkle transforms Ricky Brown’s
case from a mundane drug-trafficking prosecution into the harbinger of a
larger conflict about to break out in the federal court system.
Mr. Brown held a medical marijuana card issued under the Michigan
Medical Marihuana Act,5 and the amount of the drug he possessed (2.1
ounces)6 was well within the amount allowed for personal use under the
state medical marijuana law (2.5 ounces).7 Although a medical marijuana
license granted under state law does not serve as a defense to a federal pos-
session charge,8 the district court in Mr. Brown’s case went beyond reiterat-
ing that established federal preemption principle.9 The judge granted a
1. Brief for Plaintiff-Appellee at 4–5, United States v. Brown, No. 13-1761 (6th Cir. Apr.
2, 2014), 2014 WL 1400248 [hereinafter Government Appellate Brief].
2. Id. at 4–5.
3. Id. at 5.
4. Id. at 5–6; see 18 U.S.C. § 924(c)(1)(A) (2012) (possession of a firearm in further-
ance of drug trafficking); 21 U.S.C. § 841(a)(1), (b)(1)(D) (2012) (possession with intent to
distribute).
5. Michigan Medical Marihuana Act §§ 1–10, Mich. Comp. Laws Ann.
§§ 333.26421–.26430 (West 2014).
6. See Government Appellate Brief, supra note 1, at 5.
7. Mich. Comp. Laws Ann. § 333.26424(a) (West 2014) (“[T]he qualifying patient
[may] possess[ ] an amount of marihuana that does not exceed 2.5 ounces of usable mari-
huana . . . . ”).
8. See infra notes 15–22 and accompanying text.
9. United States v. Brown, No. 11-20281-D1 (E.D. Mich. May 10, 2012) [hereinafter
Brown Order] (“Evidence, testimony, questioning or arguments regarding Michigan’s state or
May 2015] Proving Personal Use 1257
motion in limine10 barring Mr. Brown from mentioning either his medical
card or its tendency to show that he possessed the small amount of mari-
juana found in his home for personal use.11 This excluded evidence would
have been crucial to Mr. Brown’s defense on both the charge of possession
with intent to distribute and the charge of possession of a firearm in further-
ance of a drug-trafficking crime.12 The district court excluded this critical
“personal use evidence” based on its interpretation of Federal Rules of Evi-
dence 401, 402, and 403.13
Before analyzing the admissibility of personal use evidence14 in federal
marijuana-trafficking prosecutions, it is important to distinguish three con-
versations with which this Note does not engage. This Note does not ex-
amine (1) whether a defendant can offer a state medical marijuana license as
a defense to federal drug possession charges or related questions of federal
preemption,15 (2) the “medical necessity” of marijuana,16 or (3) normative
questions about whether marijuana should be legal. A brief examination of
these related topics, however, provides a useful foundation for this Note’s
central analysis of the admissibility of personal use evidence in federal mari-
juana-trafficking prosecutions.
First, federal courts have consistently held that state marijuana legaliza-
tion efforts have no impact on federal laws that criminalize the possession of
marijuana.17 The Controlled Substances Act (“CSA”) classifies marijuana as
local laws on medical marijuana will not be allowed at trial.”), appeal docketed, No. 13-1761
(6th Cir. May 31, 2013).
10. For a detailed explanation of motions in limine, see generally Jeffrey F. Ghent, Anno-
tation, Modern Status of Rules as to Use of Motion in Limine, 63 A.L.R. 3d 311 (1975).
11. See Brown Order, supra note 9.
12. See 18 U.S.C. § 924(c)(1)(A) (2012); 21 U.S.C. § 841(a)(1), (b)(1)(D) (2012).
13. Brown Order, supra note 9; see Fed. R. Evid. 401; Fed. R. Evid. 403; Government’s
Motion in Limine to Preclude Certain Evidence, Questioning and Testimony, United States v.
Brown, No. 11-20281-D1 (E.D. Mich. Feb. 9, 2012) [hereinafter Brown Motion in Limine].
14. For purposes of this Note, “personal use evidence” is defined as evidence regarding
the amount of marijuana permitted under state medical- or recreational-use laws and evidence
that a defendant suffers from a disease that marijuana arguably treats. See infra note 30 and
accompanying text.
15. Legal commentators have thoroughly addressed these federal preemption questions,
especially in the months following Gonzales v. Raich, 545 U.S. 1 (2005). See, e.g., Ilya Somin,
Gonzales v. Raich: Federalism as a Casualty of the War on Drugs, 15 Cornell J.L. & Pub. Pol’y
507 (2006); see also infra notes 17–23 and accompanying text.
16. See, e.g., United States v. Oakland Cannabis Buyers’ Coop., 532 U.S. 483, 491 (2001)
(“[A] medical necessity exception for marijuana is at odds with the terms of the Controlled
Substances Act. . . . [T]he defense is unavailable.”).
17. See, e.g., Raich, 545 U.S. at 29 (stating in the context of a conflict between the Cali-
fornia Compassionate Use Act and the federal CSA that the “Supremacy Clause unambigu-
ously provides that if there is any conflict between federal and state law, federal law shall
prevail”).
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a prohibited Schedule I drug.18 Therefore, even if a state law legalizes mari-
juana for medical or recreational use, the CSA still authorizes federal prose-
cution by operation of preemption doctrine19 and the Supremacy Clause.20
Commentators agree that the “seminal case of Gonzales v. Raich affirmed the
constitutionality of the CSA even as applied to extremely localized mari-
juana-related activities.”21 Consequently, this Note does not argue that per-
sonal use evidence, like the possession of a medical marijuana card in Mr.
Brown’s case, qualifies as even minimally probative evidence in a federal
prosecution for marijuana possession.22 Rather, this Note examines the evi-
dence in the separate context of prosecution for trafficking or distribution.23
Second, this Note does not examine whether federal marijuana-traffick-
ing defendants may rely on the affirmative defense of medical necessity. The
medical necessity defense—in the context of marijuana prosecutions—is a
variation of the common law necessity defense that applies “where physical
forces beyond the actor’s control rendered illegal conduct the less of two
evils.”24 In United States v. Oakland Cannabis Buyers’ Cooperative, the Su-
preme Court held that “medical necessity is not a defense to manufacturing
and distributing marijuana.”25 The Court reasoned that “in the Controlled
Substances Act, the balance already has been struck against a medical neces-
sity exception.”26 In the wake of Oakland Cannabis, federal courts no longer
entertain medical necessity arguments in marijuana-trafficking cases, and
this Note does not argue that personal use evidence should be admitted as
probative on the question of medical necessity.27 It argues that personal use
evidence makes intent to distribute less likely.
Third, this Note does not take a position on whether marijuana should
be legal or whether marijuana has positive medical applications. The debate
over these issues has come to the forefront of our national consciousness as
18. 21 U.S.C. § 812 (2012).
19. E.g., Caleb Nelson, Preemption, 86 Va. L. Rev. 225, 261 (2000) (“If state law purports
to authorize something that federal law forbids or to penalize something that federal law gives
people an unqualified right to do, then courts would have to choose between applying the
federal rule and applying the state rule, and the Supremacy Clause requires them to apply the
federal rule.”).
20. U.S. Const. art. VI, cl. 2.
21. Todd Grabarsky, Conflicting Federal and State Medical Marijuana Policies: A Threat to
Cooperative Federalism, 116 W. Va. L. Rev. 1, 9 (2013).
22. See Controlled Substances Act, 21 U.S.C. § 841 (2012).
23. See 18 U.S.C. § 924(c)(1)(A) (2012); 21 U.S.C. § 841(a)(1), (b)(1)(D) (2012).
24. United States v. Oakland Cannabis Buyers’ Coop., 532 U.S. 483, 490 (2001).
25. Id. at 494.
26. Id. at 499.
27. See, e.g., United States v. $186,416.00 in U.S. Currency, 590 F.3d 942, 945 (9th Cir.
2010) (“The federal government has not recognized a legitimate medical use for marijuana . . .
and there is no exception for medical marijuana . . . under the federal Controlled Substances
Act.” (citation omitted)); United States v. Scarmazzo, 554 F. Supp. 2d 1102, 1109 (E.D. Cal.
2008) (“Federal law prohibiting the sale of marijuana is valid, despite any state law suggesting
medical necessity for marijuana.”).
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medical marijuana laws have proliferated28 and since Colorado and Wash-
ington legalized marijuana for recreational purposes during the 2012 elec-
tions.29 Given that these normative and scientific questions lend themselves
primarily to the fields of political science, economics, and medicine, this
Note confines its scope to analyzing the admissibility of personal use evi-
dence in federal marijuana-distribution cases.
This Note argues that district courts should not exclude personal use
evidence under Rules 402 and 403 when that evidence is offered to negate
intent to distribute in federal marijuana-trafficking prosecutions. The Note
discusses three types of personal use evidence: possession of a state-issued
medical marijuana card, evidence that a state has legalized possession of
recreational marijuana, and evidence that a defendant suffers from disease
symptoms that marijuana arguably alleviates.30 Part I examines each of these
three categories of personal use evidence and contends that district courts
will increasingly confront disputes over such evidence. Part II analyzes ob-
jections to the admissibility of personal use evidence, focusing primarily on
Rules 402 and 403 and using Mr. Brown’s case as a helpful illustration. Part
III responds to those objections and argues that personal use evidence is
probative of intent to distribute.
I. Three Scenarios in Which Proving Personal Use Is Critical
Given that drug-trafficking cases in which defendants can plausibly ar-
gue a personal use defense typically involve small amounts of marijuana,31 it
might appear that federal courts will have few opportunities to consider the
admissibility of personal use evidence like Mr. Brown’s medical marijuana
card. Federal prosecutors ostensibly have more important priorities than
prosecuting small-time drug offenders.32 The Justice Department has stated
that it will not prioritize enforcement efforts in states that have legalized the
28. See, e.g., California Compassionate Use Act of 1996, Cal. Health & Safety Code
§ 11362.5 (West 2007); Michigan Medical Marihuana Act §§ 1–10, Mich. Comp. Laws Ann.
§§ 333.26421–.26430 (West Supp. 2014).
29. Jack Healy, Voters Ease Marijuana Laws in 2 States, but Legal Questions Remain, N.Y.
Times, Nov. 8, 2012, at P15, available at http://www.nytimes.com/2012/11/08/us/politics/mari-
juana-laws-eased-in-colorado-and-washington.html.
30. More categories of personal use evidence undoubtedly exist, but this Note argues that
these three categories in particular will likely confront district courts adjudicating marijuana-
trafficking prosecutions. See infra Part I.
31. Ricky Brown’s case, for example, involved only 2.1 ounces of marijuana. See Govern-
ment Appellate Brief, supra note 1, at 5. A defendant charged with distribution of over 100
kilograms of marijuana, on the other hand, obviously could not raise a plausible personal use
theory. See United States v. Rivas, 573 F. App’x 566 (6th Cir. 2014).
32. Eric Holder has attempted to shift the Department of Justice’s priorities away from
low-level drug prosecutions. Holder Calls for New Approach to Prosecuting Low-Level Drug
Crimes, PBS NewsHour (Aug. 12, 2013), http://www.pbs.org/newshour/bb/law-july-dec13-
holder_08-12.
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possession and cultivation of small amounts of marijuana.33 This Part there-
fore examines the significance of personal use evidence.
Despite the Justice Department’s stated enforcement priorities, this Part
argues that there are at least three scenarios in which federal courts will
confront disputes over the admissibility of personal use evidence with in-
creasing frequency. Section I.A discusses the scenario in which Mr. Brown’s
case falls: marijuana-trafficking prosecutions in states that have legalized
medical marijuana. Section I.B introduces the scenario of federal marijuana-
trafficking prosecutions in states where the drug has been legalized for recre-
ational use. Section I.C considers a scenario in which a defendant—prose-
cuted in a state that has not legalized medical marijuana—can demonstrate
that she suffers from an illness that marijuana arguably treats.
A. Trafficking Prosecutions in States that Have
Legalized Medical Marijuana
Despite the Justice Department’s recent attempts to shift enforcement
efforts away from low-level drug offenses,34 federal prosecutors continue to
bring marijuana-trafficking cases involving relatively small amounts of mari-
juana in states that have legalized medical marijuana.35 These prosecutions
establish that federal courts must still settle disputes over the admissibility of
personal use evidence in small-quantity cases.36 And if states continue to
legalize medical marijuana, it follows that more defendants in marijuana-
trafficking cases will attempt to negate intent to distribute with their validly
issued state medical marijuana licenses.
33. For example, the DOJ has issued memoranda indicating that drug prosecutions in
states like Washington and Colorado will not be a department priority. See, e.g., Memorandum
from James M. Cole, Deputy Att’y Gen., U.S. Dep’t of Justice, to All U.S. Att’ys, Guidance
Regarding Marijuana Enforcement (Aug. 29, 2013), available at http://www.justice.gov/iso/
opa/resources/3052013829132756857467.pdf; see also Memorandum from David W. Ogden,
Deputy Att’y Gen., U.S. Dep’t of Justice, to Selected U.S. Att’ys, Investigations and Prosecu-
tions in States Authorizing the Medical Use of Marijuana (Oct. 19, 2009), available at http://
www.justice.gov/sites/default/files/opa/legacy/2009/10/19/medical-marijuana.pdf.
34. See supra notes 32–33 and accompanying text. The National Association of Assistant
United States Attorneys (“NAAUSA”), however, has opposed Holder’s “softer” drug priorities.
See Matt Apuzzo, Justice Dept. Starts Quest for Inmates to Be Freed, N.Y. Times, Jan. 30, 2014,
at A13, available at http://www.nytimes.com/2014/01/31/us/politics/white-house-seeks-drug-
clemency-candidates.html (discussing the NAAUSA’s opposition to Holder’s position on drug
sentencing reform).
35. See infra note 45; see also Alex Kreit, Opinion, Federal Drug Policy Should Focus on Big
Cases, N.Y. Times, (Jan. 14, 2014, 5:10 PM), http://www.nytimes.com/roomfordebate/2014/01/
14/should-drug-enforcement-be-left-to-the-states/federal-drug-policy-should-focus-on-big-
cases (“And yet, federal prosecutions aren’t reserved for drug kingpins. Plenty of low- and
mid-level drug offenders . . . find themselves in federal court.”).
36. See Letter from Jeffrey S. Niesen et al., Defense Counsel, to Eric Holder, Att’y Gen.,
U.S. Dep’t of Justice (Feb. 26, 2014), available at https://american-safe-access.s3.amazonaws
.com/documents/Holder_Letter.pdf (stating that federal prosecutors in Washington state are
ignoring the Cole memorandum and prosecuting “legitimate medical cannabis patients” who
are complying with state law).
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As of this writing, twenty-three states and the District of Columbia have
legalized medical marijuana, seven since 2012, including three in 2014.37 Ad-
ditional states have ballot initiatives or legislation pending that would legal-
ize medical marijuana.38 Polls show that a majority of doctors support
medical marijuana.39 State laws legalizing medical marijuana have been on
the books for less than ten years; most states have only recently adopted
policies allowing their residents to apply for medical marijuana cards.40 As
the drug gains wider acceptance in states that have already legalized it, and
as additional states enact similar laws, cardholders like Mr. Brown are in-
creasingly likely to face federal marijuana-trafficking prosecutions—even in
cases involving just a small amount of marijuana. The admissibility of per-
sonal use evidence in low-quantity trafficking prosecutions will substantially
influence the outcomes of such cases.
Cases brought by federal prosecutors in recent years reinforce this point.
Prosecutors charged Mr. Brown, for example, with two different marijuana-
trafficking felonies based on his possession of a mere 2.1 ounces of mari-
juana—an amount well within the 2.5 ounces allowed under the relevant
Michigan medical marijuana law.41 By comparison, Mr. Brown could have
carried nearly three times that amount in New Mexico,42 four times that
amount in California,43 and nearly eight times that amount in Oregon and
Washington.44
Mr. Brown’s case is not an outlier.45 Federal prosecutors continue to
bring drug-trafficking prosecutions even when law enforcement recovers
37. See State Medical Marijuana Laws, Nat’l Conf. St. Legislatures (Nov. 13, 2014),
http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx.
38. States with Pending Legislation to Legalize Medical Marijuana, ProCon.org (Jan. 5,
2015), http://medicalmarijuana.procon.org/view.resource.php?resourceID=002481 (collecting
sources).
39. Donna Fuscaldo, Survey: 53% of Doctors Support National Legalization of Medical
Marijuana, Fox Bus. News (Apr. 29, 2014), http://www.foxbusiness.com/personal-finance/
2014/04/29/survey-53-doctors-support-national-legalization-medical-marijuana (“Medical
marijuana . . . is still not widely prescribe[d] by doctors across the country—despite the ma-
jority of doctors . . . supporting its use. According to a survey by online medical resource
WebMD, 69% of doctors and 52% of patients polled say marijuana delivers benefits.”).
40. See supra note 37 and accompanying text.
41. See supra notes 6–7 and accompanying text.
42. N.M. Stat. Ann. § 26-2B-3 (Supp. 2007) (allowing possession of an “adequate sup-
ply”); N.M. Code R. § 7.34.2.7(D) (West, Westlaw through Jan. 1, 2015) (limiting an “ade-
quate supply” to “six (6) ounces”).
43. California Compassionate Use Act, Cal. Health & Safety Code Ann.
§ 11362.77(a) (West 2007) (allowing possession of “no more than eight ounces of dried
marijuana”).
44. Or. Rev. Stat. § 475.320(1)(a) (2013) (allowing possession of “six mature marijuana
plants and 24 ounces of usable marijuana”); Wash. Rev. Code § 69.51A.040(1)(a) (2014)
(authorizing the possession of “twenty-four ounces of useable cannabis” for medical
purposes).
45. See, e.g., United States v. Bobadilla-Pagán, 747 F.3d 26, 29 (1st Cir. 2014) (charging
defendant with possession with intent to distribute and with possessing a firearm in further-
ance of a drug trafficking offense when law enforcement recovered 7.4 ounces of marijuana
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only a small amount of marijuana. This practice is particularly common in
cases where the government files related weapons charges. In United States v.
Firestack-Harvey, five residents of a family farm were indicted on the same
charges as Mr. Brown for growing a small amount of marijuana and owning
a shotgun and hunting rifle.46 The district court granted a motion in limine
barring the defendants from mentioning both their compliance with Wash-
ington medical marijuana laws and their possession of a medical marijuana
card.47 In United States v. Duong,48 the defendant faced the same two distri-
bution and firearm charges. The defendant, who lived in a state that had
legalized medical marijuana, possessed less than half an ounce of marijuana.49
Such an amount, if properly prescribed, would have been permitted in all of
the twenty-four jurisdictions that have legalized medical marijuana.50 Never-
theless, the defendant in Duong faced the same two marijuana-trafficking
and firearm charges as Mr. Brown and the defendants in Firestack-Harvey.
In short, federal prosecutors continue to bring a considerable number of
small-quantity marijuana-trafficking cases, even as marijuana legalization
efforts have proliferated.51 A defendant’s ability to introduce evidence estab-
lishing personal use is crucial to his or her defense in these cases.
B. Trafficking Prosecutions in States that Have Legalized Recreational Use
While the preceding Section establishes that federal prosecutors bring an
appreciable number of marijuana-trafficking prosecutions even when only
small quantities of the drug are involved, it deals solely with a scenario in
which a defendant possesses a validly issued state medical marijuana card.
Section I.B presents a second, related scenario reinforcing the significance of
personal use evidence given the advent of state laws legalizing recreational
marijuana use. The growing support for legalization indicates that even de-
fendants who are not prescribed the drug for medical purposes will attempt
to introduce evidence that they possessed a drug quantity permissible under
their states’ recreational use law, thus negating intent to distribute.
and a gun from his car); United States v. Madina, 474 F. App’x 919, 920 (4th Cir. 2012) (per
curiam) (charging defendant with possession with intent to distribute marijuana and with
possessing a firearm in furtherance of a drug trafficking offense when law enforcement found
approximately five ounces of marijuana on his person and a shotgun in his car); United States
v. Firestack-Harvey, No. CR-13-24-FVS, 2014 WL 1682863 (E.D. Wash. Apr. 29, 2014); United
States v. Duong, No. 3:10-CR-9 VLB, 2011 WL 2413521 (D. Conn. June 10, 2011); see also
supra note 37 and accompanying text.
46. Superseding Indictment at 2–3, United States v. Firestack-Harvey, No. CR-13-24-
FVS (E.D. Wash. May 6, 2014); see 18 U.S.C. § 924(c)(1)(A) (2012); 21 U.S.C. § 841(a)(1),
(b)(1)(D) (2012).
47. Order Re Affirmative Defenses, United States v. Firestack-Harvey at 8–11, No. CR-
13-24-FVS (E.D. Wash. May 7, 2014) [hereinafter Firestack-Harvey Order].
48. 2011 WL 2413521 (D. Conn. June 10, 2011).
49. Duong, 2011 WL 2413521, at *2 (“In addition to the loaded firearm, officers also
located and seized approximately 13.7 grams of marijuana . . . . ”).
50. See supra notes 37, 42–44 and accompanying text.
51. See supra notes 41, 45 and accompanying text.
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Just a few years ago, marijuana legalization seemed fanciful.52 Not any-
more.53 Voters in Colorado and Washington made history in 2012 when they
adopted the first laws making “it legal to smoke pot recreationally, without
any prescription or medical excuse.”54 Now, even some states “in the con-
servative South[ ] are considering decriminalizing the drug or legalizing it
for medical or recreational use.”55 Members of both major parties favor le-
galization: “the two states considered likeliest . . . to follow Colorado and
Washington in outright legalization of the drug are Oregon, dominated by
liberal Democrats, and Alaska, where libertarian Republicans hold sway.”56
Furthermore, the Obama administration issued guidelines in early 2014 “in-
tended to give banks confidence that they will not be punished if they pro-
vide services to legitimate marijuana businesses . . . even though it remains
illicit under federal law.”57 The national momentum behind states’ efforts to
legalize possession of small amounts of recreational marijuana raises the
possibility that even more trafficking defendants will introduce personal use
evidence relating to recreational marijuana than evidence involving medical
marijuana.
C. Patients Who Use Illegal Medical Marijuana
to Treat Debilitating Disease
The previous two scenarios consider defendants only in states that have
legalized marijuana for medical or recreational use. While the number of
those states is fast increasing,58 neither scenario speaks to whether the ad-
missibility of personal use evidence affects defendants in the states that have
not yet legalized marijuana. Part I.C addresses prosecutions in those states
by introducing a final scenario involving personal use evidence. This scena-
rio involves defendants who use marijuana to treat illness even though their
state has not legalized medical marijuana.59 A defendant would admit her
52. Art Swift, For First Time, Americans Favor Legalizing Marijuana, Gallup (Oct. 22,
2013), http://www.gallup.com/poll/165539/first-time-americans-favor-legalizing-mari-
juana.aspx (noting that “only 12% [of Americans] favored legalization” when Gallup first
polled the question in 1969).
53. Id. (“And now for the first time, a clear majority of Americans (58%) say the drug
should be legalized.”).
54. Healy, supra note 29, at P15.
55. Rick Lyman, Pivotal Point Is Seen on Legalizing Marijuana, N.Y. Times, Feb. 27, 2014,
at A1, available at http://www.nytimes.com/2014/02/27/us/momentum-is-seen-as-more-states-
consider-legalizing-marijuana.html. (“Alabama, Georgia and South Carolina are among the
states considering [medical marijuana legalization] laws.”).
56. Id.
57. Serge F. Kovaleski, U.S. Issues Marijuana Guidelines for Banks, N.Y. Times, Feb. 15,
2014, at A10, available at http://www.nytimes.com/2014/02/15/us/us-issues-marijuana-guide-
lines-for-banks.html.
58. See supra notes 52–56 and accompanying text.
59. See How Many People in the United States Use Medical Marijuana?, ProCon.org
(2012), http://medicalmarijuana.org/view.answers.php?questionID=00119 (projecting based
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illegal possession under both state and federal law, but she would negate in-
tent to distribute by showing that marijuana relieves the symptoms of her
illness, thereby increasing the likelihood that she possessed the drug only for
personal use.
This scenario will play out in federal court with increasing frequency if
medical applications for marijuana continue to gain mainstream acceptance.
Many state legislatures have undertaken rigorous fact-finding missions to
determine whether marijuana has positive medical applications. A number
of policymakers have concluded that the drug does relieve the symptoms of
several debilitating diseases.60 Any of the millions of patients who suffer
from one of these diseases61 could present evidence regarding her illness and
treatment regimen to negate intent to distribute if she, like Mr. Brown, faced
prosecution for marijuana-trafficking based on possession of a small
amount of the drug.62
A New York judge battling cancer recently illustrated how personal use
evidence would militate against intent to distribute. In a letter to his state’s
legislature,63 Judge Gustin L. Reichbach explained his illegal marijuana use
by stating that with his disease, “[n]ausea and pain are constant compan-
ions. One struggles to eat . . . . [Sleep] becomes increasingly elusive. Inhaled
marijuana is the only medicine that gives me some relief from nausea, stim-
ulates my appetite, and makes it easier to fall asleep.”64 If marijuana’s medi-
cal applications gain wide acceptance, defendants with symptoms like Judge
Reichbach’s will certainly attempt to introduce those symptoms as evidence
that they too possessed marijuana for symptom relief, not distribution.
on an extrapolation from the number of legal medical marijuana users and 2011 census statis-
tics that there are hundreds of thousands of illegal medical marijuana users in states that have
not passed medical marijuana laws).
60. See, e.g., N.J. Stat. Ann. § 24:6I-1 (West 2014) (concluding that marijuana can re-
lieve pain or help treat “other symptoms associated with certain debilitating medical condi-
tions” including cancer, glaucoma, HIV, multiple sclerosis, and wasting syndromes).
61. See, e.g., Office of Population Affairs, Hepatitis C: The Facts 2 (2012), availa-
ble at http://www.hhs.gov/opa/pdfs/hepatitis-c-fact-sheet.pdf (“An estimated 3.2 million peo-
ple in the United States are living with chronic hepatitis C infection . . . according to the
Centers for Disease Control and Prevention.”); U.S. Statistics, AIDS.gov, http://aids.gov/hiv-
aids-basics/hiv-aids-101/statistics (last updated Dec. 2, 2014) (“More than 1.2 million people
in the United States are living with HIV infection . . . . ”).
62. See Kreit, supra note 35.
63. Gustin L. Reichbach, Op-Ed., A Judge’s Plea for Pot, N.Y. Times, May 17, 2012, at
A27, available at http://www.nytimes.com/2012/05/17/opinion/a-judges-plea-for-medical-ma-
rijuana.html (“I did not foresee that after having dedicated myself for 40 years to a life of the
law . . . my quest for ameliorative and palliative care would lead me to marijuana.”).
64. Id.
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II. Objections to the Admissibility of Personal Use
Evidence on Direct
The three scenarios presented above establish that the admissibility of
personal use evidence65 in federal marijuana-trafficking prosecutions is not
only crucial to a defendant’s case, but also a question that federal courts will
confront with increasing frequency. The remainder of this Note therefore
examines the admissibility of personal use evidence under the Federal Rules
of Evidence. Part II considers government objections that have been raised
to exclude personal use evidence from trial. Section II.A analyzes an objec-
tion to personal use evidence based on Rule 402. Section II.B considers an
objection under Rule 403.
Ricky Brown’s case provides a typical example of the government’s
strategy for excluding personal use evidence in low-quantity marijuana-traf-
ficking prosecutions.66 In Brown, the government made a motion in limine
under Rules 402 and 403 to “preclude [Mr. Brown] from making any refer-
ence, including any evidence, testimony, [or] questioning,” to three issues:
“state or local laws regarding medical marijuana,” “[t]he ‘medical necessity’
of marijuana,” and Mr. Brown’s “beliefs about such laws or marijuana.”67
The government offered two distinct lines of reasoning to support this mo-
tion: (1) under Rule 402, these “issues are irrelevant to whether the Govern-
ment can prove the crimes charged in the indictment, and do not support
any cognizable defense to the charges,” and (2) under Rule 403, these issues
“are also prejudicial.”68
A. Government Rule 402 Objections to Personal Use Evidence
District courts have granted government motions in limine to exclude
personal use evidence in marijuana-trafficking prosecutions under Rules 401
and 402.69 Those rules establish that only relevant evidence is admissible,
and evidence is relevant only if it has some “tendency to make a fact [of
consequence] more or less probable.”70 Federal prosecutors advance three
arguments supporting the conclusion that evidence of a defendant’s state
65. For purposes of this Note, “personal use evidence” is defined as evidence regarding
the amount of marijuana permitted under state medical or recreational use laws and evidence
that a defendant suffers from disease symptoms that marijuana arguably treats. See supra note
30 and accompanying text
66. See supra notes 1–13 and accompanying text. Although the admissibility of personal
use evidence in low-quantity marijuana-trafficking prosecutions is still an emerging issue, see
supra notes 31–33, other prosecutors have already adopted strategies similar to the govern-
ment’s strategy in Brown. See, e.g., Motion in Limine Regarding Medical Marijuana at 6–7,
United States v. Firestack-Harvey, No. CR-13-24-FVS (E.D. Wash. Apr. 30, 2014) [hereinafter
Firestack-Harvey Motion in Limine].
67. Brown Motion in Limine, supra note 13, at 5.
68. Id.
69. Firestack-Harvey Order, supra note 47, at 11; Brown Order, supra note 9.
70. Fed. R. Evid. 401(a); Fed. R. Evid. 402 (“Irrelevant evidence is not admissible.”).
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marijuana license and compliance with state law are irrelevant in a prosecu-
tion for possession with intent to distribute.71
First, the government argues that testimony regarding a state medical
marijuana law—including the amount of marijuana permitted—is irrele-
vant because it “is indisputable that state medical-marijuana laws do not,
and cannot, supersede federal laws that criminalize the possession of mari-
juana.”72 This argument does not address whether state medical marijuana
laws might relate to the mens rea elements of possession with intent to dis-
tribute or possession of a firearm in furtherance of a drug-trafficking crime.73
The government’s argument relates solely to simple possession.
Second, the government asserts that evidence related to compliance with
state medical marijuana laws is irrelevant because the Supreme Court has
established that “medical necessity is not a defense to manufacturing and
distributing marijuana.”74 This argument implicitly assumes that evidence of
state medical marijuana law is only probative of one potential “fact of conse-
quence” in a trafficking prosecution: whether marijuana establishes a neces-
sity defense. The government reasons that since the Supreme Court has
foreclosed marijuana-trafficking defendants from relying on the medical ne-
cessity defense, personal use evidence makes no fact of consequence more or
less likely and should therefore be excluded under Rule 402.75
Third, the government moves to exclude testimony about compliance
with state marijuana laws because “mistake of law” is not a defense to pos-
session with intent to distribute.76 Consequently, a defendant cannot assert
that she relied in good faith on state laws legalizing marijuana.77 Again, this
argument implicitly assumes that evidence of compliance with state medical
marijuana laws is only offered to support a mistake of law defense. It does
not address whether possession of a state-issued marijuana license or other
personal use evidence might satisfy Rule 402 by making intent to distribute
more or less likely.
71. See Firestack-Harvey Motion in Limine, supra note 66; Brown Motion in Limine,
supra note 13.
72. See Brown Motion in Limine, supra note 13, at 6 (quoting United States v. Hicks, 722
F. Supp. 2d 829, 833 (E.D. Mich. 2010) (internal quotation marks omitted)).
73. 18 U.S.C. § 924(c)(1)(A) (2012); 21 U.S.C. § 841(a)(1), (b)(1)(D) (2012). The court
in Firestack-Harvey did, however, acknowledge that personal use evidence might be relevant
for this “limited purpose.” Firestack-Harvey Order, supra note 47, at 9.
74. United States v. Oakland Cannabis Buyers’ Coop., 532 U.S. 483, 494 (2001); see supra
notes 25–27 and accompanying text.
75. See, e.g., Firestack-Harvey Motion in Limine, supra note 66, at 4–7; Brown Motion in
Limine, supra note 13, at 7–8.
76. See, e.g., Firestack-Harvey Order, supra note 47, at 5–6; Brown Motion in Limine,
supra note 13, at 8.
77. See, e.g., Firestack-Harvey Order, supra note 47, at 6; Brown Motion in Limine, supra
note 13, at 9.
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B. Government Rule 403 Objections to Personal Use Evidence
District courts have also sustained government objections to personal
use evidence in marijuana-trafficking cases based on Rule 403. Rule 403
states that a judge “may exclude relevant evidence if its probative value is
substantially outweighed by a danger of one or more of the following: unfair
prejudice, confusing the issues, misleading the jury, undue delay, wasting
time, or needlessly presenting cumulative evidence.”78 Federal prosecutors
support motions in limine to exclude personal use evidence by arguing un-
fair prejudice, confusion of the issues, and incitement of jury nullification.79
The government argues, and at least one district court has recognized,
that admitting personal use evidence regarding a defendant’s compliance
with state law would “confuse the jury with respect to whether compliance
with the state [law]” amounts to an affirmative defense to the crime of pos-
session with intent to distribute.80 Jurors could easily misunderstand the
complicated federalism doctrines that allow state marijuana laws to coexist
alongside the federal prohibition codified in the Controlled Substances Act.81
The government also contends that this type of issue confusion is “irrelevant
and prejudicial” to the United States, and thus Rule 403 precludes the ad-
mission of personal use evidence.82
Federal prosecutors further assert that personal use evidence violates
Rule 403 because it misleads the jury by inciting jury nullification.83 Jury
nullification is a jury’s “deliberate rejection of the evidence or refusal to
apply the law either because the jury wants to send a message about some
social issue that is larger than the case itself or because the result dictated by
law is contrary to the jury’s sense of justice, morality, or fairness.”84 A trial
judge “may block defense attorneys’ attempts to serenade a jury with the
siren song of nullification,”85 and courts have noted that personal use evi-
dence “could tempt the jury to disregard federal law.”86 One federal prosecu-
tor has supported a motion in limine by claiming that “[t]he only purpose
78. Fed. R. Evid. 403.
79. See, e.g., United States’ Response to Defendant’s Motion to Present Affirmative De-
fenses at 12–13, United States v. Gregg, No. CR-13-24-FVS (E.D. Wash. Dec. 24, 2013) [here-
inafter Firestack-Harvey Response]; Brown Motion in Limine, supra note 13, at 9–11.
80. See Firestack-Harvey Order, supra note 47, at 10; Brown Motion in Limine, supra
note 13, at 10.
81. See supra notes 17–21 and accompanying text.
82. Firestack-Harvey Response, supra note 79, at 2, 12–13; see also Firestack-Harvey Or-
der, supra note 47, at 9–10;.
83. See Firestack-Harvey Response, supra note 79, at 12–13; Brown Motion in Limine,
supra note 13, at 10.
84. Black’s Law Dictionary 989 (10th ed. 2014).
85. United States v. Sepulveda, 15 F.3d 1161, 1190 (1st Cir. 1993).
86. Firestack-Harvey Order, supra note 47, at 10; accord Brown Order, supra note 9.
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for introducing” evidence of state marijuana law “is to invite jury nullifica-
tion.”87 The government therefore asserts that even if evidence of compli-
ance with state marijuana law was relevant under Rule 402, the danger of
unfair prejudice, confusion of the issues, and potential for jury nullification
presented by such personal use evidence substantially outweighs its limited
probative value, necessitating exclusion under Rule 403.88
III. Responses to Government Personal Use Evidence Objections
Defense attorneys representing clients charged with small-quantity ma-
rijuana-trafficking offenses can raise several arguments in answer to the gov-
ernment’s attempt to exclude personal use evidence under Rules 402 and
403. Part III presents several such arguments. Section III.A responds to Rule
402 objections raised by the government. Section III.B responds to Rule 403
objections.
A. Response to Rule 402 Objections Raised by the Government
A defendant responding to a Rule 402 objection must first identify the
fact of consequence that the evidence makes more or less likely.89 Relevance
is a relational concept—nothing is “relevant” in a vacuum—so the propo-
nent of any item of evidence must establish the element of the charge or
defense on which the evidence is probative.90 A number of the government’s
Rule 402 objections implicitly assume that evidence of state marijuana laws
is solely probative of necessity or mistake of law defenses.91 A defendant
must prove those assumptions false by offering an alternate purpose for the
personal use evidence. Once the proponent identifies a proper purpose, “a
district court . . . may not exclude the evidence if it has the slightest proba-
tive worth.”92
Evidence that a defendant accused of marijuana-trafficking had a medi-
cal marijuana license, possessed an amount permitted by a state recreational
use law, or had a medical motive for possession is probative of the mens rea
element of the crimes of possession with intent to distribute and possession
of a firearm in furtherance of a drug-trafficking conspiracy.93 If a defendant
proves she complied with state laws regulating recreational marijuana use, a
jury could infer that the defendant more likely possessed the drug for per-
sonal use than for distribution. Similarly, if a defendant offers evidence that
she had a state-issued medical card or that she illegally used marijuana to
87. Brown Motion in Limine, supra note 13, at 10.
88. Id. at 9–10.
89. Fed. R. Evid. 401; Fed. R. Evid. 402.
90. See Richard O. Lempert, Samuel R. Gross & James S. Liebman, A Modern Ap-
proach to Evidence 215–23 (5th ed. 2013) (discussing Rules 401 and 402).
91. See supra notes 73–75 and accompanying text.
92. United States v. Whittington, 455 F.3d 736, 738–39 (6th Cir. 2006).
93. 18 U.S.C. § 924(c)(1)(A) (2012); 21 U.S.C. § 841(a)(1), (b)(1)(D) (2012).
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treat an illness, a jury could infer that the defendant did not have intent to
distribute given her plausible reason for personal use.
By arguing that personal use evidence is relevant to the mens rea ele-
ment of marijuana-trafficking crimes, defense attorneys can render the gov-
ernment’s federal supremacy, mistake of law, and medical necessity
arguments inapposite. A defendant accused of distribution acknowledges the
supremacy of federal law by admitting guilt on a simple possession charge;
she offers evidence of compliance with state law solely to negate intent to
distribute marijuana.94 At least one district court otherwise hostile to per-
sonal use evidence acknowledged its relevance for this “limited purpose.”95
By arguing that the evidence relates to mens rea, a defendant can refute the
assumption that such evidence is probative only of the disapproved mistake
of law and medical necessity defenses.
B. Response to Rule 403 Objections Raised by the Government
A defendant accused of marijuana trafficking must begin her response
to a Rule 403 objection by noting that a court should only exclude otherwise
relevant evidence under that rule when the probative value of the evidence is
substantially outweighed by the danger of unfair prejudice.96 The burden of
establishing substantial unfair prejudice is not on the proponent—in this
case a defendant offering personal use evidence—but rather on the govern-
ment.97 Given the tendency of personal use evidence to negate the mens rea
element of marijuana-trafficking crimes,98 the government bears a heavy
burden in attempting to exclude the evidence. Defendants should be pre-
pared to respond to both the government’s confusion of the issues and jury
nullification arguments under Rule 403.
Defendants can address concerns about issue confusion and jury nul-
lifaction by stipulating that compliance with state marijuana laws or a medi-
cal motive for marijuana use do not present a defense to federal possession
charges.99 Counsel can explain in her opening statement and closing argu-
ment, and the judge can explain in jury instructions, that while the defen-
dant admits criminal liability for possession, she disputes having the intent to
distribute required for a trafficking conviction. While jury nullification can
94. This approach does not present a defense to simple possession, but given the much
stricter federal penalties for drug-trafficking crimes, this might be a defense attorney’s best
option.
95. Firestack-Harvey Order, supra note 47, at 9.
96. See Fed. R. Evid. 403; see also Gross et al., supra note 90, at 239–40 (discussing
Rule 403’s proponent-friendly balancing test).
97. See, e.g., United States v. Tse, 375 F.3d 148, 164 (1st Cir. 2004).
98. See supra notes 94–96 and accompanying text.
99. See, e.g., Brief of Appellant Ricky Brown at 46, United States v. Brown, No. 13-1761
(6th Cir. Feb. 3, 2014) (conceding the illegality of possession under federal law).
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be a valid concern in federal possession cases,100 Rule 403’s proponent-
friendly balancing test supports introduction of personal use evidence as
probative of the issue of mens rea in a distribution case.101
A marijuana-trafficking defendant can bolster her response to a govern-
ment Rule 403 objection by appealing to the trial judge’s ability to issue a
limiting instruction to the jury. Both prosecutors and judges often rely on
limiting instructions to justify the admission of what can be the most preju-
dicial evidence available against a defendant: evidence of prior crimes,
wrongs, or acts under Rule 404(b).102 Defense attorneys could argue that if a
limiting instruction can control the jury’s use of Rule 404(b) evidence—
evidence that can be far more unfairly prejudicial than personal use evi-
dence in a marijuana-trafficking case—a limiting instruction could similarly
mitigate the risk of issue confusion or jury nullification. Given the high pro-
bative value of personal use evidence as to mens rea, and given the trial
judge’s ability to control the presentation of evidence, district courts should
admit personal use evidence over the government’s objection.
Conclusion
District courts should not exclude “personal use evidence” under Fed-
eral Rules of Evidence 402 and 403 when such evidence is offered for the
purpose of negating intent to distribute in federal marijuana-trafficking
prosecutions. Given the proliferation of state marijuana laws, district courts
will confront such disputes over evidence with increasing frequency, and the
admissibility of evidence regarding medical use and compliance with state
law is essential to a defendant’s ability to disprove mens rea in distribution
cases.
100. See, e.g., Paul Butler, Op-Ed., Jurors Need to Know that They Can Say No, N.Y. Times,
Dec. 20, 2011, at A39, available at http://www.nytimes.com/2011/12/21/opinion/jurors-can-
say-no.html.
101. See supra notes 96–98 and accompanying text.
102. Fed. R. Evid. 404(b) (“Evidence of a crime, wrong, or other act . . . may be admissi-
ble for . . . proving motive, opportunity, intent, preparation, plan, knowledge, identity, ab-
sence of mistake, or lack of accident.”); 22B Charles Alan Wright & Kenneth W.
Graham, Jr., Federal Practice and Procedure § 5249, at 201 (2014) (“The principal de-
vice for controlling the use of other crimes, wrongs, or acts is the limiting instruction.”).
